Professional Documents
Culture Documents
Graduate School
Roxas City Capiz
Extension Classes @
Garcia College of Technology
Kalibo, Aklan
MICROBIOLOGY
SCI. 413
ENTEROCOCCUS
In 2005 there were 7066 reported cases of bacteraemia caused by Enterococcus species in the
UK, an 8% increase from 2004, with the Health Protection Agency stating that “an increase in a
bacteraemia causing pathogen like this has not been observe for some time”. Twenty-eight percent of
all cases were antibiotic resistant. The risk of death from vancomycin-resistant enterococci (VRE) is
75%, compared with 45% for those infected with a susceptible strain. This dramatic increase of
antibiotic resistance of Enterococcus species worldwide highlights the need for a greater
understanding of this genus, including its ecology.
Bacteremia
Bacteria is usually transient presence of bacteria in the blood wherein Enterococci are
currently the second leading cause of healthcare-associated bacteremia. In the last few years, the
source of a bacteremia is usually the genitourinary tract, although a bacteremia also often arises from
intra-abdominal or biliary sources, indwelling central lines or soft tissue infections. Enterococci are
found as a component of polymicrobial bacteremia more often than other organisms.
Endocarditis
Endocarditis is the inflammation of the lining of the heart and its valves. It is also one of the
most serious enterococcal infections Because of the enterococci’s intrinsic resistance to the
bactericidal activity of most antibiotics, treatment is difficult, even when relatively susceptible
enterococci are involved. Two drugs exhibit synergistic killing are required for effective therapy. In the
situations of VRE or high-level aminoglycoside-resistant enterococcal endocarditis, antibiotic
treatment often fails, and surgery to remove the infect valve is essential.
The initial source of bacteremia leading to endocarditis is usually the genitourinary or
gastrointestinal (GI) tract. The most problematic current issue in the management of enterococcal
endocarditis is the selection of effective therapy for multidrug-resistant isolates.